Savara (SVRA) EBITDA Margin (2013 - 2020)

Savara (SVRA) reported EBITDA Margin of 1305200.0% for Q4 2020, down 30470.1% quarter-over-quarter from 4269.53% in Q3 2020.

Savara (SVRA) EBITDA Margin (2013 - 2020) Analysis & Trends

Savara (SVRA) has 5 years of EBITDA Margin data on file, last reported at 1305200.0% in Q4 2020.

  • EBITDA Margin for Q4 2020 came in at 1305200.0%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2022 was 4187300.0% (changed N/A YoY), and the FY2020 annual result was 18932.3%, changed N/A from the prior year.
  • EBITDA Margin eased to 1305200.0% in Q4 2020 per SVRA's latest filing, from 4269.53% in the prior quarter.
  • Over five years, EBITDA Margin peaked at 11332.98% in Q2 2017 and troughed at 1305200.0% in Q4 2020.
  • A 3-year average of 218584.98% and a median of 4704.45% in 2020 frame the typical range for EBITDA Margin.
  • On a YoY basis, EBITDA Margin climbed as much as 3938283 bps in 2016 and fell as far as 3938283 bps in 2016.
  • A 3-year view of EBITDA Margin shows it stood at 1149.5% in 2016, then soared by 1086 bps to 11332.98% in 2017, then tumbled by 11617 bps to 1305200.0% in 2020.
  • Business Quant data shows SVRA's EBITDA Margin at 1305200.0% in Q4 2020, 4269.53% in Q3 2020, and 11332.98% in Q2 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -6.43%
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 38.10%
9 Abivax 90.15 Bn 90.15 Bn - -
10 Savara 1.33 Bn 1.33 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2020 -1,305,200.00%
Sep 30, 2020 -4,269.53%
Jun 30, 2017 11,332.98%
Mar 31, 2017 -5,139.36%
Dec 31, 2016 -1,149.50%
Sep 30, 2016 -7,084.44%
Dec 31, 2015 38,233.33%
Jun 30, 2013 -973.14%
Mar 31, 2013 -1,405.78%